Redefining Brain Health
We are building a brain health digital platform for the aging population, by leveraging our proprietary bei™ (brain engagement index) technology. Brainmarc’s bei™ derived therapy platform is clinically proven to treat a variety of cognitive deficiency conditions, including: Post Stroke, TBI (Traumatic Brain Injury) and MCI (Mild Cognitive Impairment).
Brainmarc’s real-time bei™ marker, is currently featured in clinical studies across the U.S., Canada, EU, and Israel, and has proven to lead to significantly positive outcomes in various clinical applications
Short sampling time, single-channel EEG, is a remarkably easy to use setup for clinics and home settings.
The proprietary algorithm extracts the BEI™, a clinically proven marker which indicates the patient’s engagement during therapy sessions
Brinmarc’s solution significantly increases the activation of brain regions involved in therapy processes, and may lead to the formation of compensatory connections to overcome reduced activity in these regions. Increases in attention-driven activation results in greater brain plasticity, which may underlie effective outcomes across a wide variety of conditions.
Therapy powered by Brainmarc
Patients with cognitive deficiency conditions suffer from low engagement in their own therapy process. Clinical studies show that therapy is most effective when patients are fully engaged and committed. As it is difficult to evaluate and recruit the level of a patients’ engagement, an objective marker derived therapy is highly impactful for a variety of cognitive diseases.
"I believe brain engagement should be a key decision-making factor in each therapy session in clinics and at home"